{"id":960,"date":"2021-06-08T10:38:17","date_gmt":"2021-06-08T09:38:17","guid":{"rendered":"https:\/\/www.mathys-squire.com\/scaleup-quarter\/?p=960"},"modified":"2023-06-28T12:54:24","modified_gmt":"2023-06-28T11:54:24","slug":"uk-government-launches-innovation-grant-competition-for-healthcare-and-life-sciences-smes","status":"publish","type":"post","link":"https:\/\/www.mathys-squire.com\/scaleup-quarter\/uk-government-launches-innovation-grant-competition-for-healthcare-and-life-sciences-smes\/","title":{"rendered":"Biomedical Catalyst 2021: UK government launches innovation grant competition for healthcare and life sciences SMEs"},"content":{"rendered":"\n
<\/div>
\n
\n

Biomedical Catalyst 2021 – Healthcare grant for SMEs<\/h1>\n\n\n\n

<\/p>\n<\/div><\/div>\n<\/div><\/div>

08 June
2021<\/div><\/div>\n\n\n\n
<\/div>\n\n\n \n
\n
\n \n
\n

2 mins<\/p>\n <\/div>\n <\/div>\n<\/div>\n\n\n

Healthcare innovation has hardly been out of the headlines over the last 18 months, with the COVID-19 pandemic acting as a catalyst for invention. In a crowded market defined by new ideas, securing a strong IP position for your business is more important than ever.<\/strong> Now, UK-based SMEs and micro-enterprises focusing on innovative solutions to healthcare challenges can compete for government funding of up to 70% of their costs \u2013 including costs for IP protection \u2013 under the Biomedical Catalyst 2021 scheme<\/a>.<\/strong><\/p>\n\n\n\n

UK registered businesses can apply for a share of up to \u00a318 million of funding from Innovate UK (part of UK Research and Innovation), to put towards developing innovative healthcare products, technologies and processes, with project costs between \u00a3250,000 and \u00a34 million. Full eligibility requirements are available here<\/a>.<\/p>\n\n\n\n

The competition opened on Monday 7 June and runs until Thursday 26 August at 11am – for more details and to submit an application, visit the gov.uk website<\/a>.<\/p>\n\n\n\n

<\/div>\n\n\n \n